News AbbVie waits on data from Humira successor Ablynx's vobarilizumab seen as key should Humira sales fall.
News US regulatory advisers to review Amgen's Humira biosimilar World's biggest selling drug could face competition.
News Biosimilar switching not suitable for all patients Antibodies against originator will also target biosimilar.
News Gilead claims first FDA nod for a hepatitis D therapy At its second attempt, Gilead has won FDA approval for chronic hepatitis D virus drug Hepcludex, four years after it was cleared in the EU.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
